EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Managing Hidradenitis Suppurativa with Biologics and Small Molecule Inhibitors

Victoria Fang, Radhika Gupta, Robert G Micheletti

Dermatologic Clinics · 2025

DOI: 10.1016/j.det.2024.12.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025. Verfasst von Victoria Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Biological Products, Anti-Inflammatory Agents, Dermatologic Agents. Die Arbeit nennt 97 Literaturangaben. Gefördert von: InflaRx.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

"Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant quality-of-life impact. In addition to the 2 drugs approved by the Food and Drug Administration for HS, adalimumab and secukinumab, several other biologic and small molecule inhibitors are used off-label or are in clinical trials. A systematic and evidence-based approach using these and other therapies-considering patient comorbidities, response to therapy, dose adjustment, and frequent troubleshooting-is required. In this article, we review the latest evidence supporting anti-inflammatory biologic and small molecule therapies for HS and provide a practical, algorithmic approach to management incorporating experience and expert opinion."

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaBiological ProductsAnti-Inflammatory AgentsDermatologic AgentsHumansAntibodies, Monoclonal, HumanizedAdalimumab

Stichwörter der Autor:innen

BiologicBiosimilarHidradenitis suppurativaIL-1IL-12/23IL-17JAKSmall molecule inhibitorTNF

Substanzen

Antibodies, Monoclonal, HumanizedBiological ProductsAdalimumabsecukinumabAnti-Inflammatory AgentsDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, PCAM 7 South, Room 724, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA. Electronic address: Robert.Micheletti@pennmedicine.up…

Förderung

  • InflaRx

Zitieren

APA

Fang, V., Gupta, R., & Micheletti, R. G. (2025). Managing Hidradenitis Suppurativa with Biologics and Small Molecule Inhibitors. Dermatologic Clinics. https://doi.org/10.1016/j.det.2024.12.008

Vancouver

Fang V, Gupta R, Micheletti RG. Managing Hidradenitis Suppurativa with Biologics and Small Molecule Inhibitors. Dermatologic Clinics. 2025. doi:10.1016/j.det.2024.12.008

BibTeX
@article{Fang2025,
  author = {Fang, Victoria and Gupta, Radhika and Micheletti, Robert G},
  title = {Managing Hidradenitis Suppurativa with Biologics and Small Molecule Inhibitors},
  journal = {Dermatologic Clinics},
  year = {2025},
  doi = {10.1016/j.det.2024.12.008}
}
Kostenlos starten →